Parkinson's Disease Trial, Recruiting NCT07498686 Sponsor: Xuanwu Hospital, Beijing Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07498686
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with primary Parkinson's disease (PD) based on the 2015 Movement Disorder Society diagnostic standards, meeting either a confirmed or probable diagnosis.
  • People who are patients at the outpatient clinic of Xuanwu Hospital, affiliated with Capital Medical University, where a specialist in movement disorders has completed their clinical assessment and diagnosis.
  • People who are willing to sign an informed consent form agreeing to take part in the study.
  • People who are able to complete a detailed set of assessments covering medical history, disease status, movement symptoms, mental state, mood, sleep, and other related factors.
  • People diagnosed with Multiple System Atrophy (MSA) who meet the 2008 diagnostic criteria set by the European Multiple System Atrophy Study Group (confirm with trial site).
  • People diagnosed with Dementia with Lewy Bodies (DLB) who meet the 2017 diagnostic criteria for that condition (confirm with trial site).

Who may not be able to join:

  • People who have a Parkinson's-like condition that is not classified as primary Parkinson's disease.
  • People who have previously had brain surgery or have had deep brain stimulation electrodes implanted.
  • People who have been diagnosed with dementia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the American Psychiatric Association. Note: people with mild cognitive impairment (mild thinking or memory difficulties that do not meet the full definition of dementia) are not excluded on this basis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 010-83198271

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
15 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

slope; MAX

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov